Unlocking the Potential of the Probiotic Bifidobacterium Longum and Bifidobacterium Breve: A Comprehensive Guide

The concept of probiotics, which encompasses strains such as Bifidobacterium longum, can be traced back to the early 20th century. The Russian scientist Elie Metchnikoff, a Nobel laureate at the Pasteur Institute, was the pioneer who proposed the idea that the consumption of beneficial bacteria could have a positive impact on health and contribute to longevity. Metchnikoff’s hypothesis was inspired by his observations of Bulgarian peasants, whose remarkable longevity he attributed to their regular consumption of fermented milk products rich in lactic acid bacteria.

Bifidobacterium Longum: A Beneficial Bacterium

Bifidobacterium longum is a Gram-positive, anaerobic bacterium that is naturally found in various parts of the mammalian body, such as the gastrointestinal tract, vagina, and mouth. This bacterium is particularly noteworthy for its ability to metabolize dietary carbohydrates, compete against pathogenic bacteria, and bolster the immune system. Its role in human health is multifaceted, contributing to the maintenance of a balanced gut microbiota and supporting various physiological functions.

Clinical Studies and Probiotic Potential

Over the years, the probiotic potential of Bifidobacterium longum has been the subject of numerous clinical studies. These studies have explored its effects on a range of health aspects, including gastrointestinal health, immune response, and even mental well-being. For instance, a study published in 2022 examined the effects of a probiotic mixture containing Bifidobacterium longum on brain responses during an emotional attention task in healthy subjects, suggesting that probiotics can influence brain function via the microbiome-gut-brain axis [4].

Another clinical trial in 2023 demonstrated the safety and efficacy of early probiotic supplementation with Bifidobacterium longum in healthy infants, leading to the development of a Bifidobacterium-predominant gut microbiota [8]. Additionally, research has shown the safety and probiotic potential of Bifidobacterium longum strains isolated from various sources, including breast milk and healthy human gut, with no observed antibiotic resistance or mutagenic activity [9].

Further studies have investigated the effect of Bifidobacterium longum on disease severity and quality of life in patients with irritable bowel syndrome (IBS), showing improvements in symptoms and well-being [5]. The protective effects of milk phospholipids on Bifidobacterium longum during in vitro digestion and their enhancement of polysaccharide production have also been highlighted [10].

Probiotics in Preventive Healthcare

The utilization of Bifidobacterium longum in probiotic supplements and functional foods is aimed at improving the microbial balance within the human body, thereby promoting overall health and wellness. The burgeoning interest in probiotics is part of a larger trend towards preventive healthcare and acknowledges the vital role that the gut microbiome plays in maintaining health. The extensive research on Bifidobacterium longum underscores its significance as a probiotic and its potential applications in various health-related fields.

Pros of Probiotic Bifidobacterium Longum

Digestive Health Benefits

Bifidobacterium longum has been extensively studied for its role in maintaining a healthy gut microbiota, which is essential for overall digestive health. Clinical studies have shown that this probiotic can alleviate gastrointestinal symptoms such as bloating and constipation. For instance, a study demonstrated that Bifidobacterium longum 35624 effectively improved symptoms of irritable bowel syndrome (IBS), including bloating and constipation, enhancing the quality of life for patients [6]. Additionally, it has been noted for its ability to prevent and treat various forms of diarrhea [11][12].

Immune System Support

Research indicates that Bifidobacterium longum plays a significant role in supporting the immune system. It enhances the body’s ability to fend off infections and illnesses. A specific study highlighted that Bifidobacterium longum subsp. longum BB536 increased the expression of immune markers in plasmacytoid dendritic cells, suggesting a boost in innate and adaptive immune responses [15]. Another study found that Bifidobacterium longum supplementation could accelerate fracture repair in aged mice by modulating the immune response and reducing inflammation [14].

Mental Health Improvements

The interaction between Bifidobacterium longum and the gut-brain axis may contribute to improved mental health outcomes. Clinical trials have shown that strains like Bifidobacterium longum NCC3001 can reduce symptoms of anxiety and depression in perinatal women, suggesting a potential therapeutic role for this probiotic in managing mood disorders [13]. Another study involving a probiotic mixture containing Bifidobacterium longum affected brain responses during emotional tasks in healthy subjects, further supporting its role in mental health [4].

Nutrient Absorption Enhancement

While direct clinical evidence linking Bifidobacterium longum to enhanced nutrient absorption is limited, the probiotic’s role in maintaining a balanced gut environment can indirectly support the better absorption of essential nutrients. A healthy gut microbiota, facilitated by probiotics like Bifidobacterium longum, is crucial for the optimal digestion and uptake of nutrients from the diet.

Anti-inflammatory Properties

Bifidobacterium longum has demonstrated anti-inflammatory properties in various studies. For example, it has been shown to protect against inflammatory bowel disease (IBD) by modulating immune responses and maintaining gut microbiota balance in clinical settings [6]. Additionally, its anti-inflammatory effects have been observed in contexts such as alleviating allergic airway responses in a murine model, where it modulated gut microbiota and reduced inflammatory cytokines [16].

Cons of Probiotic Bifidobacterium Longum

Digestive Discomfort

Clinical studies have indicated that while Bifidobacterium longum is generally well-tolerated, some individuals may experience digestive discomfort such as gas, bloating, or diarrhea, particularly during the initial phase of supplementation. This response is often due to the adjustment period of the gut microbiota to the new probiotic strains [17][18].

Risks for Immunocompromised Individuals

For individuals with compromised immune systems, the introduction of live bacteria such as Bifidobacterium longum can pose a risk. Although rare, there is a potential for probiotics to cause infections in this vulnerable group. Clinical oversight is recommended when administering probiotics to immunocompromised patients to monitor for any adverse effects [17][7].

Allergic Reactions and Additives

Probiotic supplements, including those containing Bifidobacterium longum, can sometimes include prebiotics or other additives that may trigger allergic reactions or other side effects in sensitive individuals. The presence of these additives can vary by brand and formulation, emphasizing the need for consumers to carefully check product labels [17][19].

Quality Control Issues

The probiotic supplement industry sometimes faces challenges related to quality control. Variations in the manufacturing process can lead to discrepancies between the actual content of Bifidobacterium longum in the product and what is listed on the label. This inconsistency can affect the efficacy of the supplement and may lead to unexpected health responses [17][19].

Cost and Efficacy Variability

The cost of Bifidobacterium longum supplements can be relatively high, and their efficacy may vary significantly depending on factors such as brand reputation, specific strains used, and storage conditions. These variables can influence the cost-effectiveness of using these supplements as a regular part of health management [17][19].

Over-reliance on Supplements

There is a concern that reliance on probiotic supplements like Bifidobacterium longum might lead individuals to overlook other crucial aspects of dietary health, such as consuming a balanced diet rich in natural probiotics and fiber. Maintaining a diverse and balanced diet is essential for overall gut health and can sometimes be overshadowed by the focus on supplement intake [17][19].

Recent Development of Probiotic Bifidobacterium Longum

Exploration of Bifidobacterium Longum in Mental Health

Modulation of Gut Microbiota and Brain Function

Recent clinical studies have been focusing on the role of Bifidobacterium longum in mental health, particularly its potential to alleviate symptoms of stress, anxiety, and depression through the gut-brain axis. The gut-brain axis is a bidirectional communication pathway that allows the gut microbiota to influence brain function and behavior. Bifidobacterium longum is being studied as a psychobiotic, a type of probiotic that may positively affect mental health by modulating the gut microbiota.

Clinical Trials and Psychobiotics

Clinical trials have been conducted to assess the efficacy of Bifidobacterium longum in improving mental health outcomes. For example, the research “A Probiotic Intervention With Bifidobacterium longum NCC3001 on Perinatal Mood Outcomes (PROMOTE Study)” was designed to explore if this specific probiotic could alleviate symptoms of depression, anxiety, and stress during the perinatal period through a decentralized clinical trial approach [13].

Another trial investigated the effects of a probiotic mixture containing Bifidobacterium longum on brain responses to an arithmetic stress task in healthy subjects, finding subtle alterations in brain activity and functional connectivity in regions known to regulate emotion and stress responses [22].

Potential Benefits for Mental Health Management

The research into Bifidobacterium longum suggests that it could be a natural and effective option for managing mental health issues through dietary supplementation. The strain has been shown to have antidepressant efficacy in a chronic mild stress mouse model of depression, where it attenuated anxiety- and depressive-like behaviors and reversed immune changes in the hippocampus [20]. Additionally, a study on Lactobacillus mucosae and Bifidobacterium longum found that they synergistically alleviated immobilization stress-induced anxiety/depression in mice by suppressing gut dysbiosis [21].

Implications for Future Research and Treatment

The promising findings from these studies indicate that Bifidobacterium longum has the potential to become an integral part of strategies aimed at managing mental health conditions. As research continues to accumulate, the use of Bifidobacterium longum and other psychobiotics could lead to new, non-pharmacological treatments for mood disorders and contribute to the growing field of the microbiota-gut-brain axis [23].

What are the Probiotics functional food supplement alternatives to Probiotic Bifidobacterium Longum?

Probiotic Bifidobacterium longum is a widely used probiotic that offers various health benefits, particularly for the gastrointestinal tract. However, there are several other probiotics that can serve as functional food supplement alternatives, each with unique properties and health benefits. These include:

1. Lactobacillus acidophilus: This probiotic is commonly found in yogurt and other fermented foods. It helps in reducing cholesterol, improving symptoms of irritable bowel syndrome (IBS), and enhancing the absorption of nutrients.
2. Lactobacillus rhamnosus GG (LGG): Known for its robust nature and ability to survive stomach acid, LGG can aid in the prevention and treatment of gastrointestinal infections and diarrhea, and it has been shown to have positive effects on allergic conditions such as eczema.
3. Saccharomyces boulardii: This is a yeast-based probiotic that is particularly effective in the prevention and treatment of diarrhea resulting from antibiotic use or Clostridioides difficile infections. It’s also used for general digestive problems.
4. Bifidobacterium bifidum: Similar to B. longum, B. bifidum helps maintain a healthy balance of gut flora and is important for digesting dietary fiber, preventing infection, and producing vitamins and other important chemicals.
5. Bifidobacterium lactis: This strain is noted for its ability to stimulate immune responses and improve digestion. It can also enhance overall gut health and can be particularly beneficial in treating symptoms of constipation.
6. Streptococcus thermophilus: Often used in the production of yogurt and cheese, this probiotic helps break down lactose and thus can be beneficial for individuals with lactose intolerance. It also contributes to a reduced risk of antibiotic-associated diarrhea.

Each of these probiotics offers different benefits, and the choice of which to use can depend on specific health needs or desired outcomes. It’s also common to use a combination of different probiotic strains to achieve a broader range of benefits.

Practical Significance of Probiotic Bifidobacterium Breve

Digestive Health and Diarrhea Prevention

Bifidobacterium breve has been extensively studied for its role in maintaining digestive health and preventing diarrhea. Clinical trials have shown that this probiotic can significantly impact the management of gastrointestinal disorders. For instance, a study demonstrated that Bifidobacterium breve, along with other strains, effectively prevented antibiotic-associated diarrhea in children, highlighting its role in maintaining a balanced gut microbiota during antibiotic treatment [28].

Additionally, Bifidobacterium breve has been used to treat acute diarrhea in children, showing significant immunomodulatory effects and clinical efficacy as a probiotic adjuvant [26].

Immune System Enhancement

The immunomodulatory properties of Bifidobacterium breve are well-documented. It has been shown to enhance immune function by modulating cytokine production and immune cell activity. For example, Bifidobacterium breve has been found to promote antitumor efficacy through the recruitment of dendritic cells and the upregulation of interleukin 12, which plays a crucial role in immune response [29].

This probiotic also exhibits effects on systemic inflammation, as seen in studies where it alleviated collagen-induced arthritis in rats by modulating gut microbiota and enhancing intestinal barrier function [30].

Allergy and Autoimmune Disorder Reduction

Bifidobacterium breve‘s potential to reduce the incidence of allergies and autoimmune disorders is linked to its ability to regulate the immune system. While direct clinical evidence specifically linking Bifidobacterium breve to reduced allergies and autoimmune conditions is limited, its overall immunomodulatory effects suggest a beneficial impact.

Probiotics, including Bifidobacterium breve, are known to influence the pathogenesis of allergic diseases by affecting the gut microbiota’s composition and the immune system’s response [27].

Mental Health Through the Gut-Brain Axis

The influence of Bifidobacterium breve on mental health via the gut-brain axis is an emerging area of research. Studies have shown that strains like Bifidobacterium breve CCFM1025 can improve sleep quality and potentially reduce stress-related disorders by regulating the activity of the hypothalamic-pituitary-adrenal (HPA) axis [31]. Additionally, its role in emotional regulation has been observed in studies where it mitigated anxiety-like behavior and memory impairment in mice [25].

Application in Food Production

In the food industry, Bifidobacterium breve is utilized for its fermentative properties, particularly in the production of dairy products. It helps ferment lactose and other sugars, enhancing the texture and flavor of products like yogurt and cheese. This application not only improves food quality but also adds health benefits to dairy products by incorporating probiotics that support digestive health [24].

What are the differences between Probiotic Bifidobacterium Longum and Probiotic Bifidobacterium Breve? What happens when both of these two Probiotic Bifidobacterium Longum and Probiotic Bifidobacterium Breve are combined in a health dietary supplement?

Bifidobacterium breve and Bifidobacterium longum are both species of probiotic bacteria that are commonly found in the human gut, particularly in the intestines. They play crucial roles in health, including digestion, immune function, and potentially even mental health. However, there are some differences between these two species in terms of their physiological effects and applications.

Differences between Bifidobacterium breve and Bifidobacterium longum:

1. Colonization and Adaptation: B. breve is particularly adept at colonizing the guts of infants, where it helps to digest the sugars in human milk that are important for infant nutrition and development. B. longum, on the other hand, is more prevalent in the adult gut and is known for its ability to break down a wider variety of complex carbohydrates, which adults are more likely to consume.
2. Health Benefits: Both species offer health benefits, but their effects can differ. B. breve has been shown to help alleviate gastrointestinal disorders, improve skin health, and reduce the severity of allergies. It is particularly noted for its ability to help restore gut flora balance quickly, which is beneficial in conditions like diarrhea. B. longum is often highlighted for its anti-inflammatory properties and its ability to boost the immune system. It may also help reduce gastrointestinal discomfort from conditions like irritable bowel syndrome (IBS) and has been studied for its potential in reducing anxiety and alleviating stress-related symptoms.
3. Survival and Stability: The ability of these probiotics to survive through the gastrointestinal tract and colonize the gut can vary. B. longum tends to be more resistant to lower pH levels, making it slightly better at surviving the acidic environment of the stomach. B. breve, while also capable of surviving stomach acid to a degree, may require more careful formulation to ensure it reaches the gut effectively in functional amounts.

Combining Bifidobacterium breve and Bifidobacterium longum in a dietary supplement:

When combined in a nutraceutical supplement, B. breve and B. longum can offer a synergistic effect that enhances the overall balance of gut flora, potentially leading to improved gut health and immune function. The combination can cater to a broader range of gastrointestinal environments and dietary habits, making the supplement effective for a wider audience.

1. Enhanced Efficacy: The combination can potentially address multiple gastrointestinal issues simultaneously, such as reducing inflammation, promoting nutrient absorption, and alleviating symptoms of lactose intolerance or allergies.
2. Broader Protective Effects: With both strains present, the protective effects against pathogenic bacteria are enhanced, as each strain may inhibit different groups of harmful bacteria or yeasts.
3. Comprehensive Support: By influencing different parts of the immune system, their combined action can potentially offer more comprehensive immune support, reducing the likelihood of infections and possibly even improving response to vaccines.

In conclusion, while B. breve and B. longum individually offer specific health benefits, their combination in a dietary supplement can provide a more balanced and effective approach to maintaining gut health and overall well-being. This makes such supplements particularly appealing for individuals looking to support their digestive health and immune system comprehensively.

Pros of Probiotic Bifidobacterium Breve

Digestive Health and Nutrient Absorption

Clinical studies have demonstrated that Bifidobacterium breve plays a significant role in maintaining a healthy digestive system. It is particularly abundant in the guts of breastfed infants, where it assists in the digestion of milk and complex carbohydrates [2734]. This probiotic strain promotes a balanced gut microbiota, which is crucial for proper digestion and nutrient absorption. A study on Bifidobacterium breve B-3 showed that it secretes bioactive factors that enhance barrier function in human intestinal Caco-2 cells, indicating its potential to support intestinal health [37].

Immune Function Enhancement

Bifidobacterium breve has been shown to alter immune function and ameliorate inflammation. For instance, Bifidobacterium breve alters immune function in weanling rats, suggesting its potential to reduce the frequency and severity of respiratory infections and allergies [32]. This probiotic strain’s ability to enhance immune function is further supported by a study where oral administration of Bifidobacterium breve promoted antitumor efficacy via dendritic cells-derived interleukin 12, highlighting its immunomodulatory effects [36].

Prevention of Diarrhea

The probiotic strain Bifidobacterium breve is known to help prevent diarrhea, including antibiotic-associated diarrhea. It competes with harmful bacteria for nutrients and attachment sites in the gut, which can prevent the growth of pathogenic bacteria. A study evaluating the immunomodulatory effects of Bifidobacterium spp. found that Bifidobacterium breve and Bifidobacterium longum groups showed significant immunomodulatory effects on the expression levels of various cytokines, which could contribute to the prevention of acute diarrhea in children [38].

Management of IBS and Inflammatory Bowel Diseases

Bifidobacterium breve may also be beneficial in managing symptoms of irritable bowel syndrome (IBS) and other inflammatory bowel diseases (IBD). A study on the pre-test probability of inflammatory bowel diseases highlighted the importance of distinguishing between IBS and forms of IBD, such as Crohn’s disease and ulcerative colitis, before colonoscopy [33]. While Bifidobacterium breve is not specifically mentioned in this study, the overall importance of gut microbiota in these conditions is emphasized.

Metabolic Health

Research suggests that Bifidobacterium breve can influence metabolic functions through gut microbiota interactions, potentially reducing the risk of intestinal infections and combating obesity and metabolic issues. A randomized clinical trial found that Bifidobacterium breve supplementation significantly improved glycemic control, lipid profile, and microbiome composition in subjects with type 2 diabetes mellitus (T2DM), indicating its role in metabolic health [24].

Safety and Versatility

Bifidobacterium breve is considered safe for most people, including infants and the elderly, making it a versatile addition to dietary supplements. Its safety and efficacy have been demonstrated in various clinical trials, such as the PROPAM study, which showed that a mixture containing Bifidobacterium breve could reduce asthma exacerbations in children [35].

Recent Development of Probiotic Bifidobacterium Breve

Gastrointestinal Health Improvement

In adults, Bifidobacterium breve has been studied for its potential to improve gastrointestinal health. A randomized clinical trial evaluating the influence of Bifidobacterium breve supplementation on glycemic control, lipid profile, and microbiome of Type 2 Diabetic subjects found that B. breve significantly reduced levels of blood-urea nitrogen, creatinine, LDL, triglycerides, and glycated hemoglobin, indicating its beneficial effects on metabolic health [24].

Management of Allergies and Metabolic Syndrome

The potential benefits of Bifidobacterium breve extend to the management of allergies and metabolic syndrome. A study on the blood cholesterol improvement functionality of Bifidobacterium breve IDCC 4401 heat treatment culture powder highlighted its cholesterol-improving functionality, providing an alternative to HMG-CoA reductase inhibitors for healthy and semi-healthy people managing their blood cholesterol [39].

References:

[1] Chichlowski, Maciej, et al. “Bifidobacterium Longum Subspecies Infantis (B. Infantis) in Pediatric Nutrition: Current State of Knowledge.” Nutrients, vol. 12, no. 6, 28 May 2020, p. 1581, doi:10.3390/nu12061581, www.ncbi.nlm.nih.gov/pmc/articles/PMC7352178/. Accessed 20 Apr. 2024.

[2] Moreno-Muñoz, José Antonio, Manel Martín-Palomas, and Jesús Jiménez López. “[Bifidobacterium Longum Subsp. Infantis CECT 7210 (B. Infantis IM-1®) Shows Activity against Intestinal Pathogens].” Nutr Hosp., vol. 39, Spec No3, 1 Sep. 2022, pp. 65-68, doi:10.20960/nh.04315, www.pubmed.ncbi.nlm.nih.gov/36039996/. Accessed 20 Apr. 2024.

[3] Edebol Carlman, Hanna M. T., et al. “Probiotic Mixture Containing Lactobacillus Helveticus, Bifidobacterium Longum and Lactiplantibacillus Plantarum Affects Brain Responses to an Arithmetic Stress Task in Healthy Subjects: A Randomised Clinical Trial and Proof-of-Concept Study.” Nutrients, vol. 14, no. 7, 2022, p. 1329, doi:10.3390/nu14071329, www.ncbi.nlm.nih.gov/pmc/articles/PMC9002567/. Accessed 20 Apr. 2024.

[4] Rode, Julia, et al. “Probiotic Mixture Containing Lactobacillus Helveticus, Bifidobacterium Longum and Lactiplantibacillus Plantarum Affects Brain Responses Toward an Emotional Task in Healthy Subjects: A Randomized Clinical Trial.” Frontiers in Nutrition, vol. 9, 2022, doi:10.3389/fnut.2022.827182, www.ncbi.nlm.nih.gov/pmc/articles/PMC9104811/. Accessed 20 Apr. 2024.

[5] Sabaté, Jean-Marc, and Franck Iglicki. “Effect of Bifidobacterium Longum 35624 on Disease Severity and Quality of Life in Patients with Irritable Bowel Syndrome.” World Journal of Gastroenterology, vol. 28, no. 7, 21 Feb. 2022, pp. 732-744, doi:10.3748/wjg.v28.i7.732, www.ncbi.nlm.nih.gov/pmc/articles/PMC8891724/. Accessed 20 Apr. 2024.

[6] Yao, Shunyu, et al. “Bifidobacterium Longum: Protection Against Inflammatory Bowel Disease.” PubMed Central (PMC), 21 July 2021, www.ncbi.nlm.nih.gov/pmc/articles/PMC8324359/. Accessed 20 Apr. 2024.

[7] Mills, Susan, et al. “Efficacy of Bifidobacterium longum Alone or in Multi-Strain Probiotic Formulations During Early Life and Beyond.” Gut Microbes, vol. 15, no. 1, 2023. PubMed Central, doi:10.1080/19490976.2023.2186098. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012958/. Accessed 21 Apr. 2024.

[8] Hiraku, Akari, et al. “Early Probiotic Supplementation of Healthy Term Infants with Bifidobacterium Longum Subsp. Infantis M-63 Is Safe and Leads to the Development of Bifidobacterium-Predominant Gut Microbiota: A Double-Blind, Placebo-Controlled Trial.” PubMed Central (PMC), www.ncbi.nlm.nih.gov/pmc/articles/PMC10055625/. Accessed 20 Apr. 2024.

[9] Chen, Jui-Fen, et al. “Safety Assessment and Probiotic Potential Comparison of Bifidobacterium Longum Subsp. Infantis BLI-02, Lactobacillus Plantarum LPL28, Lactobacillus Acidophilus TYCA06, and Lactobacillus Paracasei ET-66.” PubMed Central (PMC), www.ncbi.nlm.nih.gov/pmc/articles/PMC10780348/. Accessed 20 Apr. 2024.

[10] Kosmerl, Erica, et al. “Milk Phospholipids Protect Bifidobacterium Longum Subsp. Infantis During In Vitro Digestion and Enhance Polysaccharide Production.” Frontiers in Nutrition, vol. 10, 6 Nov. 2023, doi:10.3389/fnut.2023.1194945, www.ncbi.nlm.nih.gov/pmc/articles/PMC10657999/. Accessed 20 Apr. 2024.

[11] Alekseeva, Maria G., et al. “Study of the Binding of ΔFN3.1 Fragments of the Bifidobacterium Longum GT15 with TNFα and Prevalence of Domain-Containing Proteins in Groups of Bacteria of the Human Gut Microbiota.” Microbiome Research Reports, vol. 2, no. 2, 2023, doi:10.20517/mrr.2023.06, www.ncbi.nlm.nih.gov/pmc/articles/PMC10688814/. Accessed 20 Apr. 2024.

[12] Cao, Fangfang, et al. “Artificial-Enzymes-Armed Bifidobacterium Longum Probiotics for Alleviating Intestinal Inflammation and Microbiota Dysbiosis.” Nature Nanotechnology, vol. 18, no. 6, June 2023, pp. 617-627, doi:10.1038/s41565-023-01346-x, www.pubmed.ncbi.nlm.nih.gov/36973397/. Accessed 20 Apr. 2024.

[13] Toh, Melissa P. S., et al. “A Probiotic Intervention With Bifidobacterium Longum NCC3001 on Perinatal Mood Outcomes (PROMOTE Study): Protocol for a Decentralized Randomized Controlled Trial.” JMIR Research Protocols, vol. 12, 2023, www.ncbi.nlm.nih.gov/pmc/articles/PMC10131660/. Accessed 20 Apr. 2024.

[14] Roberts, Joseph L., et al. “Bifidobacterium Longum Supplementation Improves Age‐Related Delays in Fracture Repair.” Aging Cell, vol. 22, no. 4, 2023, doi:10.1111/acel.13786, www.ncbi.nlm.nih.gov/pmc/articles/PMC10086533/. Accessed 20 Apr. 2024.

[15] Li, Yiran, et al. “The Potential Immunomodulatory Effect of Bifidobacterium Longum Subsp. Longum BB536 on Healthy Adults Through Plasmacytoid Dendritic Cell Activation in the Peripheral Blood.” Nutrients, vol. 16, no. 1, 2023, doi:10.3390/nu16010042, www.ncbi.nlm.nih.gov/pmc/articles/PMC10780326/. Accessed 20 Apr. 2024.

[16] Niu, Xiaokang, et al. “Heat-Killed Bifidobacterium Longum BBMN68 in Pasteurized Yogurt Alleviates Mugwort Pollen-Induced Allergic Airway Responses through Gut Microbiota Modulation in a Murine Model.” PubMed Central (PMC), www.ncbi.nlm.nih.gov/pmc/articles/PMC10217734/. Accessed 20 Apr. 2024.

[17] Rodríguez-Sorrento, Agustina, et al. “Assessment of the Effects of the Synbiotic Combination of Bifidobacterium Longum Subsp. Infantis CECT 7210 and Oligofructose-Enriched Inulin Against Digestive Bacterial Infections in a Piglet Model.” Frontiers in Microbiology, vol. 13, 8 Mar. 2022, doi:10.3389/fmicb.2022.831737, www.ncbi.nlm.nih.gov/pmc/articles/PMC8957890/. Accessed 20 Apr. 2024.

[18] Zhuge, Aoxiang, et al. “The Synergy of Dietary Supplements Lactobacillus Salivarius LI01 and Bifidobacterium Longum TC01 in Alleviating Liver Failure in Rats Treated with D-Galactosamine.” Food Function, vol. 12, no. 20, 19 Oct. 2021, pp. 10239-10252, doi:10.1039/d1fo01807h, pubmed.ncbi.nlm.nih.gov/34546256/. Accessed 20 Apr. 2024.

[19] Yakovenko, E. P., et al. “[The Effectiveness of a Probiotic Containing Bifidobacterium Longum BB-46 and Enterococcus Faecium ENCfa-68 in the Treatment of Post-Infectious Irritable Bowel Syndrome. Prospective Randomized Comparative Study].” Ter Arkh, vol. 94, no. 2, 15 Feb. 2022, pp. 180-187, doi:10.26442/00403660.2022.02.201368, pubmed.ncbi.nlm.nih.gov/36286741/. Accessed 20 Apr. 2024.

[20] Li, Nannan, et al. “Oral Probiotics Ameliorate the Behavioral Deficits Induced by Chronic Mild Stress in Mice via the Gut Microbiota-Inflammation Axis.” Frontiers in Behavioral Neuroscience, vol. 12, 6 Nov. 2018, p. 266, doi:10.3389/fnbeh.2018.00266, www.ncbi.nlm.nih.gov/pmc/articles/PMC6232506/. Accessed 20 Apr. 2024.

[21] Han, Sang-Kap, and Dong-Hyun Kim. “Lactobacillus Mucosae and Bifidobacterium Longum Synergistically Alleviate Immobilization Stress-Induced Anxiety/Depression in Mice by Suppressing Gut Dysbiosis.” Journal of Microbiology and Biotechnology, 28 September 2019, doi:10.4014/jmb.1907.07044, www.semanticscholar.org/paper/2c888bbe1756d8baa268cb03a9ed072dd53dd8b8. Accessed 20 Apr. 2024.

[22] Edebol Carlman, Hanna M. T., et al. “Probiotic Mixture Containing Lactobacillus Helveticus, Bifidobacterium Longum and Lactiplantibacillus Plantarum Affects Brain Responses to an Arithmetic Stress Task in Healthy Subjects: A Randomised Clinical Trial and Proof-of-Concept Study.” Nutrients, vol. 14, no. 7, 2022, p. 1329, doi:10.3390/nu14071329, www.ncbi.nlm.nih.gov/pmc/articles/PMC9002567/. Accessed 20 Apr. 2024.

[23] Forssten, Sofia D., et al. “One Giant Leap from Mouse to Man: The Microbiota–Gut–Brain Axis in Mood Disorders and Translational Challenges Moving towards Human Clinical Trials.” Nutrients, doi:10.3390/nu14030568, www.ncbi.nlm.nih.gov/pmc/articles/PMC8840472/. Accessed 20 Apr. 2024.

[24] Chaiyasut, Chaiyavat, et al. “Influence of Bifidobacterium Breve on the Glycaemic Control, Lipid Profile and Microbiome of Type 2 Diabetic Subjects: A Preliminary Randomized Clinical Trial.” Pharmaceuticals (Basel), vol. 16, no. 5, 2023, doi:10.3390/ph16050695, www.ncbi.nlm.nih.gov/pmc/articles/PMC10220806/. Accessed 20 Apr. 2024.

[25] Qian, Xin, et al. “Determining the Emotional Regulation Function of Bifidobacterium Breve: The Role of Gut Metabolite Regulation Over Colonization Capability.” Food Function, vol. 15, no. 3, 5 Feb. 2024, pp. 1598-1611, doi:10.1039/d3fo02739b, pubmed.ncbi.nlm.nih.gov/38240388/. Accessed 20 Apr. 2024.

[26] Choi, Yae Jin, Seon-Hee Shin, and Hea Soon Shin. “Immunomodulatory Effects of Bifidobacterium spp. and Use of Bifidobacterium breve and Bifidobacterium longum on Acute Diarrhea in Children.” Journal of Microbiology and Biotechnology, vol. 32, no. 9, 28 Sep. 2022, pp. 1186–1194, doi:10.4014/jmb.2206.06023, www.ncbi.nlm.nih.gov/pmc/articles/PMC9628976/. Accessed 20 Apr. 2024.

[27] Zhou, Danai T., et al. “A Scoping Review of Gut Microbiome and Bifidobacterium Research in Zimbabwe: Implications for Future Studies.” Pediatric Health, Medicine and Therapeutics, vol. 14, 18 Dec. 2023, pp. 483-496, doi:10.2147/PHMT.S414766, www.ncbi.nlm.nih.gov/pmc/articles/PMC10743709/. Accessed 20 Apr. 2024.

[28] Lukasik, Jan, et al. “Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial.” JAMA Pediatrics, vol. 176, no. 9, 1 Sep. 2022, pp. 860-866, doi:10.1001/jamapediatrics.2022.1973, pubmed.ncbi.nlm.nih.gov/35727573/. Accessed 20 Apr. 2024.

[29] Li, Qingxiang, et al. “Oral Administration of Bifidobacterium Breve Promotes Antitumor Efficacy Via Dendritic Cells-Derived Interleukin 12.” Oncoimmunology, vol. 10, no. 1, 15 Jan. 2021, article 1868122, doi:10.1080/2162402X.2020.1868122, www.ncbi.nlm.nih.gov/pmc/articles/PMC7833736/. Accessed 20 Apr. 2024.

[30] Li, Bowen, et al. “Bifidobacterium Breve CCFM1078 Alleviates Collagen-Induced Arthritis in Rats via Modulating the Gut Microbiota and Repairing the Intestinal Barrier Damage.” J Agric Food Chem., vol. 70, no. 46, 23 Nov. 2022, pp. 14665-14678, doi:10.1021/acs.jafc.2c04602, pubmed.ncbi.nlm.nih.gov/36377740/. Accessed 20 Apr. 2024.

[31] Lan, Yuming, et al. “Bifidobacterium Breve CCFM1025 Improves Sleep Quality via Regulating the Activity of the HPA Axis: A Randomized Clinical Trial.” Nutrients, vol. 15, no. 21, 2023, doi:10.3390/nu15214700, www.ncbi.nlm.nih.gov/pmc/articles/PMC10648101/. Accessed 20 Apr. 2024.

[32] Izumi, Hirohisa, et al. “Bifidobacterium Breve Alters Immune Function and Ameliorates DSS-Induced Inflammation in Weanling Rats.” Pediatric Research, vol. 78, no. 4, Oct. 2015, pp. 407-416, doi:10.1038/pr.2015.115, pubmed.ncbi.nlm.nih.gov/26083761/. Accessed 20 Apr. 2024.

[33] Rasmagina, Irina A., et al. “Clinical and Laboratory Markers of the Pre-Test Probability of Inflammatory Bowel Diseases.” Koloproktologia, 2023, www.semanticscholar.org/paper/30b273534659a4c3fa2211f0165b07c2567e3ac3. Accessed 20 Apr. 2024.

[35] Drago, Lorenzo, et al. “The Probiotics in Pediatric Asthma Management (PROPAM) Study in the Primary Care Setting: A Randomized, Controlled, Double-Blind Trial with Ligilactobacillus salivarius LS01 (DSM 22775) and Bifidobacterium breve B632 (DSM 24706).” Journal of Immunology Research, vol. 2022, 17 Jan. 2022, article 3837418, doi:10.1155/2022/3837418, www.ncbi.nlm.nih.gov/pmc/articles/PMC8786459/. Accessed 20 Apr. 2024.

[36] Li, Qingxiang, et al. “Oral Administration of Bifidobacterium Breve Promotes Antitumor Efficacy Via Dendritic Cells-Derived Interleukin 12.” Oncoimmunology, vol. 10, no. 1, 2021, article 1868122, doi:10.1080/2162402X.2020.1868122, www.ncbi.nlm.nih.gov/pmc/articles/PMC7833736/. Accessed 20 Apr. 2024.

[37] Kurose, Y., et al. “Bioactive Factors Secreted by Bifidobacterium Breve B-3 Enhance Barrier Function in Human Intestinal Caco-2 Cells.” Beneficial Microbes, vol. 10, no. 1, 2019, pp. 89-100, doi:10.3920/BM2018.0062, pubmed.ncbi.nlm.nih.gov/30353739/. Accessed 20 Apr. 2024.

[38] Choi, Yae Jin, Seon-Hee Shin, and Hea Soon Shin. “Immunomodulatory Effects of Bifidobacterium spp. and Use of Bifidobacterium Breve and Bifidobacterium Longum on Acute Diarrhea in Children.” Journal of Microbiology and Biotechnology, vol. 32, no. 9, 28 Sep. 2022, pp. 1186–1194, doi:10.4014/jmb.2206.06023, www.ncbi.nlm.nih.gov/pmc/articles/PMC9628976/. Accessed 20 Apr. 2024.

[39] Kim, Min Cheol, and Min-Goo Kim. “Study on Blood Cholesterol Improvement Functionality of Bifidobacterium breve IDCC 4401 Heat Treatment Culture Powder, a Health Functional Ingredient.” Yakhak Hoeji, 2022, www.semanticscholar.org/paper/Study-on-Blood-Cholesterol-Improvement-of-breve-a-Kim-Kim/79447353ddc10c22d4185b5a21fad8461f42fd25. Accessed 20 Apr. 2024.